Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997 Jan 23. 336 (4):267-76. [QxMD MEDLINE Link].
Merlo M, Abate E, Pinamonti B, et al. Restrictive cardiomyopathy: clinical assessment and imaging in diagnosis and patient management. In: Pinamonti B, Sinagra Gianfranco, eds. Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies. Cham, Switzerland: Springer; 2014. 185-206. [Full Text].
Huby AC, Mendsaikhan U, Takagi K, et al. Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy. J Am Coll Cardiol. 2014 Dec 30. 64 (25):2765-76. [QxMD MEDLINE Link].
Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015 Oct 7. 36 (38):2585-94. [QxMD MEDLINE Link].
Schlant RC, Alexander RW, eds. The Heart. New York, NY: McGraw-Hill; 1994. 1637-45.
Higano ST, Azrak E, Tahirkheli NK, Kern MJ. Hemodynamic rounds series II: hemodynamics of constrictive physiology: influence of respiratory dynamics on ventricular pressures. Catheter Cardiovasc Interv. 1999 Apr. 46 (4):473-86. [QxMD MEDLINE Link].
Kostareva A, Kiselev A, Gudkova A, et al. Genetic spectrum of idiopathic restrictive cardiomyopathy uncovered by next-generation sequencing. PLoS One. 2016. 11 (9):e0163362. [QxMD MEDLINE Link].
Towbin JA. Inherited cardiomyopathies. Circ J. 2014. 78 (10):2347-56. [QxMD MEDLINE Link].
Peled Y, Gramlich M, Yoskovitz G, et al. Titin mutation in familial restrictive cardiomyopathy. Int J Cardiol. 2014 Jan 15. 171 (1):24-30. [QxMD MEDLINE Link].
[Guideline] Lindenfeld J, Albert NM, Boehmer JP, et al, for the Heart Failure Society of America. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010 Jun. 16(6):e1-194. [QxMD MEDLINE Link].
Davies MJ, Mann JM. Systemic pathology. The Cardiovascular System. Vol 10. New York, NY: Churchill Livingstone; 1995. 1409-16.
Wald DS, Gray HH. Restrictive cardiomyopathy in systemic amyloidosis. QJM. 2003 May. 96 (5):380-2. [QxMD MEDLINE Link].
Garcia MJ. Constrictive pericarditis versus restrictive cardiomyopathy?. J Am Coll Cardiol. 2016 May 3. 67 (17):2061-76. [QxMD MEDLINE Link].
Sasaki N, Garcia M, Ko HH, Sharma S, Parness IA, Srivastava S. Applicability of published guidelines for assessment of left ventricular diastolic function in adults to children with restrictive cardiomyopathy: an observational study. Pediatr Cardiol. 2015 Feb. 36 (2):386-92. [QxMD MEDLINE Link].
Bejar D, Colombo PC, Latif F, Yuzefpolskaya M. Infiltrative cardiomyopathies. Clin Med Insights Cardiol. 2015. 9 (suppl 2):29-38. [QxMD MEDLINE Link].
Mankad AK, Shah KB. Transthyretin cardiac amyloidosis. Curr Cardiol Rep. 2017 Aug 24. 19 (10):97. [QxMD MEDLINE Link].
Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015 Nov-Dec. 24 (6):343-50. [QxMD MEDLINE Link].
Braunwald E, Abelmann WH, eds. Atlas of Heart Diseases. Vol 2. Philadelphia, PA: Current Medicine; 1994. 53-61.
Niemann JI. Cardiomyopathies and pericardial disease. In: Tintinalli JE, Stapczynski JS, Ma OJ, et al, eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 8th ed. New York, NY: McGraw-Hill; 2016. 384.
Castano A, Bokhari S, Maurer MS. Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction. Eur Heart J. 2015 Oct 7. 36 (38):2595-7. [QxMD MEDLINE Link].
Goldstein JA. Differentiation of constrictive pericarditis and restrictive cardiomyopathy. ACC Ed Highlights. 1998 Fall. 14-22.
Amaki M, Savino J, Ain DL, et al. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ Cardiovasc Imaging. 2014 Sep. 7 (5):819-27. [QxMD MEDLINE Link].
Malik SB, Kwan D, Shah AB, Hsu JY. The right atrium: gateway to the heart--anatomic and pathologic imaging findings. Radiographics. 2015 Jan-Feb. 35 (1):14-31. [QxMD MEDLINE Link].
Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev. 2015 Mar. 20 (2):125-31. [QxMD MEDLINE Link].
Leya FS, Arab D, Joyal D, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol. 2005 Jun 7. 45 (11):1900-2. [QxMD MEDLINE Link].
Selvaganesh M, Arul AS, Balasubramanian S, Ganesan N, Naina Mohammed S, Sivakumar GS, et al. An unusual ECG pattern in restrictive cardimyopathy. Indian Heart J. 2015 Jul-Aug. 67 (4):362-7. [QxMD MEDLINE Link].
White JA, Fine NM. Recent advances in cardiovascular imaging relevant to the management of patients with suspected cardiac amyloidosis. Curr Cardiol Rep. 2016 Aug. 18 (8):77. [QxMD MEDLINE Link].
Saeed M, Liu H, Liang CH, Wilson MW. Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging. 2017 Sep. 33 (9):1395-414. [QxMD MEDLINE Link].
Leviner DB, Hochhauser E, Arad M. Inherited cardiomyopathies--novel therapies. Pharmacol Ther. 2015 Nov. 155:36-48. [QxMD MEDLINE Link].
Gursu HA, Varan B, Erdogan I. Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy. Cardiol Young. 2014 Aug. 24 (4):764-6. [QxMD MEDLINE Link].
Miller LW, Guglin M. Evaluation of ventricular assist devices and cardiac transplantation. In: Baliga R, Haas G, eds. Management of Heart Failure. London, UK: Springer-Verlag; 2015.
Sundararajan S, Thiruchelvam T, Hsia TY, Karimova A. New 15-mL ventricular assist device in children with restrictive physiology of the left ventricle. J Thorac Cardiovasc Surg. 2014 Jun. 147 (6):e79-80. [QxMD MEDLINE Link].
Grupper A, Park SJ, Pereira NL, et al. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease. J Heart Lung Transplant. 2015 Aug. 34 (8):1042-9. [QxMD MEDLINE Link].
Robinson MR, Al-Kindi SG, Oliveira GH. Heart and heart-liver transplantation in patients with hemochromatosis. Int J Cardiol. 2017 Oct 1. 244:226-8. [QxMD MEDLINE Link].
Uriel N, Vainrib A, Jorde UP, et al. Mediastinal radiation and adverse outcomes after heart transplantation. J Heart Lung Transplant. 2010 Mar. 29 (3):378-81. [QxMD MEDLINE Link].
Hanna M. Novel drugs targeting transthyretin amyloidosis. Curr Heart Fail Rep. 2014 Mar. 11 (1):50-7. [QxMD MEDLINE Link].
Madeira M, Teixeira R, Costa M, Goncalves L, Klein AL. Two-dimensional speckle tracking cardiac mechanics and constrictive pericarditis: systematic review. Echocardiography. 2016 Oct. 33 (10):1589-99. [QxMD MEDLINE Link].
Zhang Y, He L, Cai J, et al. Measurements in pediatric patients with cardiomyopathies: comparison of cardiac magnetic resonance imaging and echocardiography. Cardiology. 2015. 131 (4):245-50. [QxMD MEDLINE Link].
Topilsky Y, Pereira NL, Shah DK, et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011 May. 4 (3):266-75. [QxMD MEDLINE Link].
[Guideline] Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA, et al. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail. 2009 Mar. 15(2):83-97. [QxMD MEDLINE Link]. [Full Text].
Fritschi S, Prothmann M, Schulz-Menger J. [Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging] [German]. Herz. 2015 Jun. 40 (4):591-9. [QxMD MEDLINE Link].
DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J Heart Lung Transplant. 2012 Dec. 31 (12):1269-75. [QxMD MEDLINE Link].
[Guideline] Yancy CW, Jessup M, Bozkurt B, et al, for the Writing Committee Members, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15. 128(16):e240-327. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Ackerman MJ, Priori SG, Willems S, et al, for the Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011 Aug. 13(8):1077-109. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Ponikowski P, Voors AA, Anker SD, et al, for the European Society of Cardiology Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14. 37(27):2129-200. [QxMD MEDLINE Link]. [Full Text].
Ryan TD, Madueme PC, Jefferies JL, et al. Utility of echocardiography in the assessment of left ventricular diastolic function and restrictive physiology in children and young adults with restrictive cardiomyopathy: a comparative echocardiography-catheterization study. Pediatr Cardiol. 2017 Feb. 38 (2):381-9. [QxMD MEDLINE Link].